Flockhart passed away in 2015. He had been diagnosed with glioblastoma multiforme, an advanced type of brain cancer. Ever the teacher, Flockhart shared his personal experience with the disease through radio interviews, public forums and other avenues, addressing important issues such as access to care and inefficiencies in the health care system that place an undue burden on patients. During an interview, when asked what he wanted to achieve through the Indiana Institute for Personalized Medicine, Flockhart responded: “We want to change the world, and medicine in particular.”
YOU ARE EXPLORING
The Indiana Institute for Personalized Medicine at IU School of Medicine explores how genetic information and environmental exposure affect a person’s individual risk of developing certain diseases and their response to certain medications.
The Indiana Institute for Personalized Medicine is focused on improving the practice of medicine by advancing the personalization of therapy for a wide range of conditions—that is, finding the best drug for each patient. Scientists at the Institute for Personalized Medicine apply cutting-edge clinical, laboratory and informatics expertise to better understand why medicines work for individual patients, design new means of targeting therapies, and encourage the development of new therapies that benefit patients of all ages, genders and ethnicities.